Clinical proteomics: Current status, challenges, and future perspectives

This account will give an overview and evaluation of the current advances in mass spectrometry (MS)‐based proteomics platforms and technology. A general review of some background information concerning the application of these methods in the characterization of molecular sizes and related protein expression profiles associated with different types of cells under varied experimental conditions will be presented. It is intended to provide a concise and succinct overview to those clinical researchers first exposed to this foremost powerful methodology in modern life sciences of postgenomic era. Proteomic characterization using highly sophisticated and expensive instrumentation of MS has been used to characterize biological samples of complex protein mixtures with vastly different protein structure and composition. These systems are then used to highlight the versatility and potential of the MS‐based proteomic strategies for facilitating protein expression analysis of various disease‐related organisms or tissues of interest. Major MS‐based strategies reviewed herein include (1) matrix‐assisted laser desorption ionization‐MS and electron‐spray ionization proteomics; (2) one‐dimensional or two‐dimensional gel‐based proteomics; (3) gel‐free shotgun proteomics in conjunction with liquid chromatography/tandem MS; (4) Multiple reaction monitoring coupled tandem MS quantitative proteomics and; (5) Phosphoproteomics based on immobilized metal affinity chromatography and liquid chromatography‐MS/MS.

• Publication year

  2011

• Venue

  Kaohsiung Journal of Medical Sciences

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.kjms.2010.12.001PMID 21329886PMCID PMC11916739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Top down proteomics.

  2013cited by this paper
• Adventures in clinical chemistry and proteomics: a personal account.

  2010cited by this paper
• The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum.

  2010cited by this paper
• Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery*

  2010cited by this paper
• Proteomics in clinical chemistry: will it be long?

  2010cited by this paper
• Characterization of site-specific mutants of alkylhydroperoxide reductase with dual functionality from Helicobacter pylori.

  2010cited by this paper
• Upregulation of a non-heme iron-containing ferritin with dual ferroxidase and DNA-binding activities in Helicobacter pylori under acid stress.

  2010cited by this paper
• Mass-spectrometry-based clinical proteomics--a review and prospective.

  2010cited by this paper
• Clinical Proteomics; protein expression research within disease--A challenging task.

  2010cited by this paper
• Proteomics and disease revisited: the challenge of providing proteomic tools into clinical practice.

  2010cited by this paper
• COOH-terminal truncations and site-directed mutations enhance thermostability and chaperone-like activity of porcine αB-crystallin

  2009cited by this paper
• An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers*

  2009cited by this paper
• Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.

  2009cited by this paper
• Increased throughput for low-abundance protein biomarker verification by liquid chromatography/tandem mass spectrometry.

  2009cited by this paper
• Quantitative mass spectrometry-based techniques for clinical use: Biomarker identification and quantification

  2008cited by this paper
• Overview and introduction to clinical proteomics.

  2008cited by this paper
• A Multiplexed Quantitative Strategy for Membrane Proteomics

  2008cited by this paper
• Selected reaction monitoring for quantitative proteomics: a tutorial

  2008cited by this paper
• Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.

  2008cited by this paper
• Oxidative stress and calpain inhibition induce alpha B-crystallin phosphorylation via p38-MAPK and calcium signalling pathways in H9c2 cells.

  2008cited by this paper
• Review of a current role of mass spectrometry for proteome research.

  2008influential reference
• Charge monitoring cell mass spectrometry.

  2008cited by this paper
• Proteomic identification of biomarkers related to Helicobacter pylori‐associated gastroduodenal disease: Challenges and opportunities

  2008cited by this paper
• Differential roles of p38-MAPK and JNKs in mediating early protection or apoptosis in the hyperthermic perfused amphibian heart

  2008cited by this paper
• The Current State of Proteomics in GI Oncology

  2008cited by this paper
• Stable isotope labeling by amino acids in cell culture for quantitative proteomics.

  2007cited by this paper
• Biomarker qualification pilot process at the US Food and Drug Administration

  2007cited by this paper
• Current role of liquid chromatography–mass spectrometry in clinical and forensic toxicology

  2007cited by this paper
• Clinical Proteomics: Opportunities for Diagnostics, Pharmaceuticals and the Clinical Laboratory

  2007cited by this paper
• Proteomics: Clinical Applications

  2007cited by this paper
• Proteomics in clinical interventions: achievements and limitations in biomarker development.

  2007cited by this paper
• Capture and analysis of quantitative proteomic data

  2007cited by this paper
• How to distinguish healthy from diseased? Classification strategy for mass spectrometry‐based clinical proteomics

  2007cited by this paper
• Charge-monitoring laser-induced acoustic desorption mass spectrometry for cell and microparticle mass distribution measurement.

  2007cited by this paper
• Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks

  2007cited by this paper
• A Method for Automatically Interpreting Mass Spectra of 18O-Labeled Isotopic Clusters*S

  2007cited by this paper
• Chemistry. Mass spectrometry: bottom-up or top-down?

  2006cited by this paper
• Proteomics in Clinical Trials and Practice

  2006cited by this paper
• A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)

  2006cited by this paper
• Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.

  2006cited by this paper
• The antioxidant protein alkylhydroperoxide reductase of Helicobacter pylori switches from a peroxide reductase to a molecular chaperone function.

  2006cited by this paper
• Protein biomarker discovery and validation: the long and uncertain path to clinical utility

  2006cited by this paper
• Mass Spectrometry: Bottom-Up or Top-Down?

  2006cited by this paper
• Subcellular and Functional Proteomic Analysis of the Cellular Responses Induced by Helicobacter pylori*S

  2006cited by this paper
• Laser-induced acoustic desorption mass spectrometry of single bioparticles.

  2006cited by this paper
• A Quantitative Results-driven Approach to Analyzing Multisite Protein Phosphorylation

  2006cited by this paper
• Clinical proteomics: present and future prospects.

  2006cited by this paper
• Comprehensive screening of anabolic steroids, corticosteroids, and acidic drugs in horse urine by solid-phase extraction and liquid chromatography-mass spectrometry.

  2006cited by this paper
• Investigation of an LC-MS-MS (QTrap) method for the rapid screening and identification of drugs in postmortem toxicology whole blood samples.

  2005cited by this paper
• The clinical application of proteomics.

  2005cited by this paper
• Proteomics by FTICR mass spectrometry: top down and bottom up.

  2005cited by this paper
• The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications.

  2005cited by this paper
• Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides

  2005cited by this paper
• Multiple reaction monitoring as a method for identifying protein posttranslational modifications.

  2005cited by this paper
• Detection, quantification and confirmation of anabolic steroids in equine plasma by liquid chromatography and tandem mass spectrometry.

  2005cited by this paper
• Clinical cancer proteomics: promises and pitfalls.

  2005cited by this paper
• Proteomic analysis of proteins expressed by Helicobacter pylori under oxidative stress

  2005cited by this paper
• Multiple Reaction Monitoring to Identify Sites of Protein Phosphorylation with High Sensitivity *S

  2005cited by this paper
• Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.

  2004cited by this paper
• Peer Reviewed: Top-Down Proteomics

  2004cited by this paper
• Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S

  2004cited by this paper
• Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry.

  2004cited by this paper
• Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).

  2004cited by this paper
• Top-down proteomics.

  2004cited by this paper
• Screening newborns for inborn errors of metabolism by tandem mass spectrometry.

  2003cited by this paper
• Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC).

  2003cited by this paper
• Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

  2003cited by this paper
• Alterations in the Mouse and Human Proteome Caused by Huntington’s Disease*

  2002cited by this paper
• Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer

  2002cited by this paper
• Applications of mass spectrometry for quantitation of DNA adducts.

  2002cited by this paper
• Top-down mass spectrometry of a 29-kDa protein for characterization of any posttranslational modification to within one residue

  2002cited by this paper
• Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

  2002cited by this paper
• Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics*

  2002cited by this paper
• Shotgun identification of protein modifications from protein complexes and lens tissue

  2002cited by this paper
• Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus.

  2001cited by this paper
• High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry.

  2001cited by this paper
• Large-scale analysis of the yeast proteome by multidimensional protein identification technology

  2001cited by this paper
• Using mass spectrometry for quantitative proteomics

  2000cited by this paper
• Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology.

  2000cited by this paper
• Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines

  2000cited by this paper
• Evaluation of commonly used electrophoretic methods for the analysis of proteins and peptides and their application to biotechnology

  1999cited by this paper
• Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

  1999influential reference
• Nanoelectrospray mass spectrometry and precursor ion monitoring for quantitative steroid analysis and attomole sensitivity.

  1999cited by this paper
• Comparison of two‐dimensional electrophoresis patterns of heat shock protein Hsp27 species in normal and cardiomyopathic hearts

  1999cited by this paper
• Signaling through scaffold, anchoring, and adaptor proteins.

  1997cited by this paper
• Direct analysis and identification of proteins in mixtures by LC/MS/MS and database searching at the low-femtomole level.

  1997cited by this paper
• Analysis of polypeptide expression in benign and malignant human breast lesions

  1997cited by this paper
• Two‐dimensional electrophoretic patterns of acute‐phase human serum proteins in the course of bacterial and viral diseases

  1996cited by this paper
• Post-translational modifications of water-soluble human lens crystallins from young adults.

  1994cited by this paper
• Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases.

  1993cited by this paper
• Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry

  1988cited by this paper
• Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons.

  1988cited by this paper
• Multiple charging in electrospray ionization of poly(ethylene glycols)

  1988cited by this paper
• High resolution two-dimensional electrophoresis of proteins.

  1975cited by this paper
• Stepwise degradations and deamidation of the eye lens protein α-crystallin in ageing

  1975cited by this paper
• Stepwise degradations and deamidation of the eye lens protein alpha-crystallin in ageing.

  1975cited by this paper
• Metastable ion characteristics

  1972cited by this paper
• Metastable ion characteristics. VII. Collision-induced metastables

  1968cited by this paper
• Collision-induced decompositions of aromatic molecular ions

  1968cited by this paper
• © 2010 Molecular Vision Identification of in vivo phosphorylation sites of lens proteins from porcine eye lenses by a gel-free phosphoproteomics approach

  year unknowncited by this paper

• Proteomics and Its Current Application in Biomedical Area: Concise Review

  2024cites this paper
• SARS‐CoV‐2 in digital era: Diagnostic techniques and importance of nucleic acid quantification with digital PCRs

  2023cites this paper
• Shotgun proteomic analysis using human serum from type 2 diabetes mellitus patients

  2022cites this paper
• Proteomics: Concepts and applications in human medicine

  2021cites this paper
• Is it useful to use several “omics” for obtaining valuable results?

  2019cites this paper
• Proteomic analysis of synovial fluid: current and potential uses to improve clinical outcomes

  2019cites this paper
• Proteomics integrated with metabolomics: analysis of the internal causes of nutrient changes in alfalfa at different growth stages

  2018cites this paper
• A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer’s disease

  2017cites this paper
• Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco‐proteogenomics approach

  2016cites this paper
• Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level

  2016cites this paper
• Addition of Cryoprotectant Significantly Alters the Epididymal Sperm Proteome

  2016cites this paper
• Analysis of lifespan-promoting effect of garlic extract by an integrated metabolo-proteomics approach.

  2015cites this paper
• Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma

  2015cites this paper
• From Chemistry to Translational Medicine: The Application of Proteomics to Cancer Biomarker Discovery and Diagnosis

  2015cites this paper
• Metabolic changes in diastolic heart failure: a proteomic approach

  2015cites this paper
• Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma

  2015cites this paper
• Clinical Proteomics Identifies Urinary CD14 as a Potential Biomarker for Diagnosis of Stable Coronary Artery Disease

  2015cites this paper
• Quantitative Proteomics Analysis of Differentially Expressed Proteins Involved in Renal Clear Cell Carcinoma by Shotgun Approach Coupled with Stable Isotope Dimethyl Labeling

  2014cites this paper
• Proteomics in uveal melanoma.

  2014cites this paper
• Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases.

  2014cites this paper
• Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics

  2014cites this paper
• Shotgun Proteomics Analysis of Differentially Expressed Urinary ProteinsInvolved in the Hepatocellular Carcinoma

  2014cites this paper
• Comparative proteomics analysis of degenerative eye lenses of nocturnal rice eel and catfish as compared to diurnal zebrafish

  2013cites this paper
• Proteomics Approaches towards Early Detection and Diagnosis of Cancer

  2013cites this paper
• Genomics and Proteomics: How Long Do We Need to Reach Clinical Results?

  2013cites this paper
• Quantitative proteomics analysis of varicose veins: Identification of a set of differentially expressed proteins related to ATP generation and utilization

  2013cites this paper
• Identificación mediante proteómica de nuevas adipoquinas y mioquinas implicadas en la obesidad

  2013cites this paper
• Molecular markers for cancer prognosis and treatment: have we struck gold?

  2012cites this paper
• Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis

  2012cites this paper
• After genomics, what proteomics tools could help us understand the antimicrobial resistance of Escherichia coli?

  2012cites this paper
• Proteomics-related biomarkers for HBV-associated hepatocellular carcinoma: current status and future prospects

  2012cites this paper
• Translational research in infectious disease: current paradigms and challenges ahead

  2012cites this paper
• Obesidomics: contribution of adipose tissue secretome analysis to obesity research

  2012cites this paper
• Assessment of research models for testing gene-environment interactions.

  2011cites this paper